BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8397476)

  • 21. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tsl and LP-BM5: a comparison of two murine retrovirus models for HIV.
    Clark S; Duggan J; Chakraborty J
    Viral Immunol; 2001; 14(2):95-109. PubMed ID: 11398815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine retrovirus induces defects in the function of dendritic cells at early stages of infection.
    Gabrilovich DI; Patterson S; Harvey JJ; Woods GM; Elsley W; Knight SC
    Cell Immunol; 1994 Oct; 158(1):167-81. PubMed ID: 8087863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of retroviral propagation and disease by suramin in murine systems.
    Ruprecht RM; Rossoni LD; Haseltine WA; Broder S
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7733-7. PubMed ID: 2415971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mother-to-baby transfer of humoral immunity against retrovirus-induced neurologic disorders and immunodeficiency.
    Saha K; Hollowell D; Wong PK
    Virology; 1994 Jan; 198(1):129-37. PubMed ID: 8259648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus.
    Kubo Y; Nakagawa Y; Kakimi K; Matsui H; Iwashiro M; Kuribayashi K; Masuda T; Hiai H; Hirama T; Yanagawa S
    J Virol; 1992 Sep; 66(9):5691-5. PubMed ID: 1323720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a continuous lymphocyte cell line derived from BALB/c mice inoculated with a recombinant Moloney murine leukemia virus-TB.
    Prasad G; Wong PK; Yuen PH
    Indian J Exp Biol; 1992 May; 30(5):357-61. PubMed ID: 1459611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.
    Gabrilovich DI; Woods GM; Patterson S; Harvey JJ; Knight SC
    Immunology; 1994 May; 82(1):82-7. PubMed ID: 8045596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 30. The combined action of Rauscher leukemia virus and lactic dehydrogenase virus on mouse lymphatic tissue.
    Proffitt MR; Congdon CC; Tyndall RL
    Int J Cancer; 1972 Jan; 9(1):193-211. PubMed ID: 5015664
    [No Abstract]   [Full Text] [Related]  

  • 31. Moloney murine leukemia virus temperature-sensitive mutants: a model for retrovirus-induced neurologic disorders.
    Wong PK
    Curr Top Microbiol Immunol; 1990; 160():29-60. PubMed ID: 2162285
    [No Abstract]   [Full Text] [Related]  

  • 32. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses.
    Lee JC; Ihle JN
    J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
    Fan H
    Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis.
    Hook LM; Jude BA; Ter-Grigorov VS; Hartley JW; Morse HC; Trainin Z; Toder V; Chervonsky AV; Golovkina TV
    J Virol; 2002 Dec; 76(23):12112-22. PubMed ID: 12414952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the rapid decrease in leukemogenic potential Rauscher leukemia virus in cell culture.
    Schlom J; Moloney JB; Groupé V
    Cancer Res; 1971 Mar; 31(3):260-4. PubMed ID: 5547213
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of canthaxanthin on JB/MS melanoma growth during retroviral pathogenesis induced by LP-BM5 murine leukemia virus.
    Huang DS; Watson RR; Chen GJ; Watzl B
    Adv Exp Med Biol; 1991; 288():279-86. PubMed ID: 1659135
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice.
    Iwai H; Day NK; Hamada N; Inaba MM; Ikehara S; Good RA
    Clin Exp Immunol; 1994 Jan; 95(1):135-40. PubMed ID: 8287597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue. 3. Alterations in the thymic-dependent area induced by the passenger lactic dehydrogenase virus.
    Snodgrass MJ; Hanna MG
    J Natl Cancer Inst; 1970 Oct; 45(4):741-59. PubMed ID: 5513501
    [No Abstract]   [Full Text] [Related]  

  • 40. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    BasombrĂ­o MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.